搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
3 小时
Benralizumab beneficial for eosinophilic exacerbations of asthma, chronic obstructive ...
Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
healthday
7 小时
Benralizumab Beneficial for Eosinophilic Exacerbations of Asthma, COPD
Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulm ...
1 小时
‘My Chronic Hives Were Dismissed by Doctors for Years—Here’s How I Finally Got a ...
Diagnosing CSU can be difficult for a few main reasons, including the following: CSU is often misdiagnosed because hives are ...
Medscape
12 小时
More Biologics May Be Breaking Through for COPD
Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...
manilatimes
5 小时
Crossject launches reserved capital increase and warrants issuance for an aggregate amount ...
The proceeds of the Transaction are expected to result in a total cumulative gross amount of at least EUR 7 million in ...
Future Market Insights
19 小时
Global Pollen Allergy Market Soars to New Heights, Projected to Reach USD 8.8 Billion by ...
Pollen Allergy Market. The global pollen allergy market, valued at approximately USD 5850.8 million in 2023, is on a promising growth trajectory, driven by advancements in healthc ...
JD Supra
5 小时
Stem Cell Litigation Update: FDA Won the Latest Battle, but the Future of HCT/P Enforcement ...
On September 27, 2024, the U.S. Court of Appeals for the Ninth Circuit reversed the district court’s decision in U.S. v. California Stem ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈